Investigational New Drug Contract Development and Manufacturing Market was valued at USD 10.5 Billion in 2022 and is projected to reach USD 21.2 Billion by 2030, growing at a CAGR of 9.5% from 2024 to 2030.
The global Investigational New Drug (IND) contract development and manufacturing market is experiencing substantial growth due to increasing pharmaceutical R&D activities, rising demand for biologics, and the growing complexity of drug development. Companies are outsourcing drug formulation, analytical services, and manufacturing processes to specialized contract development and manufacturing organizations (CDMOs) to reduce costs and accelerate time-to-market. The market is further driven by advancements in technology, regulatory support for faster approvals, and the rising prevalence of chronic diseases. Emerging markets are also contributing to industry expansion due to increased investments in healthcare infrastructure and clinical trials. The competitive landscape consists of both established players and emerging firms striving to offer comprehensive solutions, from drug discovery to commercial-scale production. Strategic collaborations, mergers, and acquisitions are shaping the market dynamics as companies aim to strengthen their service portfolios and expand their geographic presence to cater to growing global demand.
Innovation in biologics and cell and gene therapies is significantly influencing the market as pharmaceutical companies seek specialized manufacturing expertise. The demand for small molecule drugs remains strong, but the increasing focus on personalized medicine is shifting industry priorities toward niche and complex formulations. Regulatory compliance remains a key challenge, with evolving guidelines requiring CDMOs to adopt advanced manufacturing technologies and robust quality control measures. Market players are leveraging automation, artificial intelligence, and continuous manufacturing to enhance efficiency and ensure high standards. The expansion of clinical trials worldwide, especially in emerging regions, is opening new opportunities for CDMOs to establish global partnerships. The increasing adoption of single-use bioprocessing and modular manufacturing systems is further streamlining production processes. As competition intensifies, service differentiation, flexibility, and the ability to support end-to-end drug development are becoming crucial factors for success in the evolving IND contract development and manufacturing landscape.
Get an In-Depth Research Analysis of the Gloabl Investigational New Drug Contract Development and Manufacturing Market Size And Forecast [2025-2032]
Â
Covance Inc.
Charles River Laboratories Inc.
Cambrex Corporation
IQVIA Holdings Inc.
Syneos Health
Lonza
Catalent
Recipharm AB
Siegfried Holding AG
Thermo Fisher Scientific Inc.
Â
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. The Asia-Pacific region is expected to be a key driver of growth, accounting for more than 35% of total revenue growth. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase of the Gloabl Investigational New Drug Contract Development and Manufacturing Market Size And Forecast [2025-2032]
Growing demand for below applications around the world has had a direct impact on the growth of the Gloabl Investigational New Drug Contract Development and Manufacturing Market
Preclinical Phase
Clinical Phase (Phase I, II, III)
Commercialization Phase
Drug Substance Manufacturing
Drug Product Manufacturing
Regulatory Affairs Services
Quality Control and Assurance Services
Packaging and Labeling Services
Oncology
Cardiovascular Diseases
Neurological Disorders
Infectious Diseases
Autoimmune Disorders
Small-Scale Operations
Mid-Scale Operations
Large-Scale Operations
Pharmaceutical Companies
Biotechnology Firms
Academic and Research Institutions
CMOs (Contract Manufacturing Organizations)
Generic Drug Manufacturers
US (United States, US and Mexico)
Europe (Germany, UK, France, Italy, Russia, Turkey, etc.)
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
South America (Brazil, Argentina, Columbia, etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
For More Information or Query, Visit @ Investigational New Drug Contract Development and Manufacturing Market Research Analysis
1. Introduction of the Gloabl Investigational New Drug Contract Development and Manufacturing Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. Gloabl Investigational New Drug Contract Development and Manufacturing Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. Gloabl Investigational New Drug Contract Development and Manufacturing Market, By Type
6. Gloabl Investigational New Drug Contract Development and Manufacturing Market, By Application
7. Gloabl Investigational New Drug Contract Development and Manufacturing Market, By Geography
US
Europe
Asia Pacific
Rest of the World
8. Gloabl Investigational New Drug Contract Development and Manufacturing Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading US Research and Consulting firm servicing over 5000+ US clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/